(Q33391647)

English

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial

scientific article

Statements

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit